Paper39334366
Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside.
Xu L and 8 others. J Transl Med, 2024. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside. Papers, record 39334366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39334366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dependovirus | Major topic |
| Genetic Therapy | Major topic |
| Neurodegenerative Diseases | Major topic |
| Genetic Vectors | Major topic |
| Humans | |
| Animals | |
| Translational Research, Biomedical | |
| Clinical Trials as Topic |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82302385 | National Natural Science Foundation of China | PubMed | ||
| 82101902 | National Natural Science Foundation of China | PubMed | ||
| NH21500323 | startup fund of Soochow University | PubMed | ||
| NH21500124 | startup fund of Soochow University | PubMed | ||
| BK20201079 | Natural Science Foundation of Jiangsu Province | PubMed | ||
| GZK12023051 | the Project of State Key Laboratory of Radiation Medicine and Protection of Soochow University | PubMed | ||
| SKY2023169 | Suzhou Municipal Science and Technology Development Project | PubMed | ||
| SDFEYBS2216 | Pre-research Foundation of the Second Affiliated Hospital of Soochow University | PubMed |
Source PubMed
References172
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30109242 | Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65. | Mol Ther Methods Clin Dev | 2018 | https://conductscience.org/library/papers/30109242 | PubMed |
| 2 | 10202534 | Etiology and pathogenesis of Parkinson's disease. | Annu Rev Neurosci | 1999 | https://conductscience.org/library/papers/10202534 | PubMed |
| 3 | 23517473 | Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. | Hum Gene Ther | 2013 | https://conductscience.org/library/papers/23517473 | PubMed |
| 4 | 21610699 | Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. | Mol Ther | 2011 | https://conductscience.org/library/papers/21610699 | PubMed |
| 5 | 22201473 | Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. | Hum Gene Ther | 2012 | https://conductscience.org/library/papers/22201473 | PubMed |
| 6 | 20595065 | Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer's disease. | Brain Behav Immun | 2010 | https://conductscience.org/library/papers/20595065 | PubMed |
| 7 | 14325163 | ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES. | Science | 1965 | https://conductscience.org/library/papers/14325163 | PubMed |
| 8 | 11082319 | Lentiviral vectors for enhanced gene expression in human hematopoietic cells. | Mol Ther | 2000 | https://conductscience.org/library/papers/11082319 | PubMed |
| 9 | 33895085 | Adeno-Associated Virus Vector for Central Nervous System Gene Therapy. | Trends Mol Med | 2021 | https://conductscience.org/library/papers/33895085 | PubMed |
| 10 | 30093643 | Gene therapy for neurological disorders: progress and prospects. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/30093643 | PubMed |
| 11 | 18400866 | In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. | J Virol | 2008 | https://conductscience.org/library/papers/18400866 | PubMed |
| 12 | 18059373 | Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose. | Mol Ther | 2008 | https://conductscience.org/library/papers/18059373 | PubMed |
| 13 | 7623375 | Rescue and replication signals of the adeno-associated virus 2 genome. | J Mol Biol | 1995 | https://conductscience.org/library/papers/7623375 | PubMed |
| 14 | 23460893 | Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound. | PLoS One | 2013 | https://conductscience.org/library/papers/23460893 | PubMed |
| 15 | 27570871 | 2016 Alzheimer's disease facts and figures. | Alzheimers Dement | 2016 | https://conductscience.org/library/papers/27570871 | PubMed |
| 16 | 19664713 | Structure and function of the blood-brain barrier. | Neurobiol Dis | 2010 | https://conductscience.org/library/papers/19664713 | PubMed |
| 17 | 7748178 | The cryptic life style of adeno-associated virus. | Bioessays | 1995 | https://conductscience.org/library/papers/7748178 | PubMed |
| 18 | 29326962 | Emerging Issues in AAV-Mediated In Vivo Gene Therapy. | Mol Ther Methods Clin Dev | 2018 | https://conductscience.org/library/papers/29326962 | PubMed |
| 19 | 31788496 | Selection of an Efficient AAV Vector for Robust CNS Transgene Expression. | Mol Ther Methods Clin Dev | 2019 | https://conductscience.org/library/papers/31788496 | PubMed |
| 20 | 17180118 | Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector. | Mol Ther | 2007 | https://conductscience.org/library/papers/17180118 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42944054 | Mapping of Pre-Existing Humoral Immunity to AAV and Natural AAV Capsid Presence in Human Tissues: Observations from a Polish Surgical Cohort. | Viruses | 2026 | https://conductscience.org/library/papers/42944054 | PubMed |
| 42740795 | Base editing rescues a hereditary motor neuron disease in mouse and patient-derived iPSC organoid models. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42740795 | PubMed |
| 42582471 | Therapeutic strategies for spinal muscular atrophy: the history and future perspective. | Front Hum Neurosci | 2026 | https://conductscience.org/library/papers/42582471 | PubMed |
| 42405669 | AAV8-Mediated Retinal PD-L1 Gene Transfer Attenuates Experimental Autoimmune Uveitis by Restoring Local Immune Tolerance. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42405669 | PubMed |
| 42339583 | Status and future of recombinant adeno-associated virus vector manufacturing. | Biotechnol Prog | 2026 | https://conductscience.org/library/papers/42339583 | PubMed |
| 42278347 | Safety of Adeno-Associated Viral Vectors in Gene Therapy: Mechanisms of Toxicity, Clinical Risks, and Strategies for Their Minimization. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278347 | PubMed |
| 42222362 | Molecular mechanisms of autophagy-lysosomal pathway dysfunction in neurodegenerative diseases and therapeutic strategies for lysosomal repair: a review. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42222362 | PubMed |
| 42180403 | Efficacy and safety of AAV-mediated gene therapy for choroideremia: a systematic review and meta-analysis. | EClinicalMedicine | 2026 | https://conductscience.org/library/papers/42180403 | PubMed |
| 42137590 | Adeno-associated virus-induced neurotoxicity is prevented by CpG depletion. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42137590 | PubMed |
| 42137269 | Design and initial characterization of a novel mini-promoter for gene therapies targeting the central nervous system. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42137269 | PubMed |
| 42074014 | CRISPR Applications in Alzheimer's Disease: From High-Throughput Genetic Screening to Precision Editing and CNS Delivery. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074014 | PubMed |
| 41869564 | Targeting of Itch by clomipramine or gene therapy improves cognitive defects related to Alzheimer's disease. | iScience | 2026 | https://conductscience.org/library/papers/41869564 | PubMed |
| 41865126 | Recent Advances in the Non-viral Delivery of Genes to Central Nervous System Disorders. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41865126 | PubMed |
| 41835941 | The delivery challenge of adeno-associated virus vector-based gene therapies for neurological diseases. | Front Neurosci | 2026 | https://conductscience.org/library/papers/41835941 | PubMed |
| 41438872 | AAV-PHP.eB achieves superior neuronal transduction over AAV9 in pigtail macaques following intracerebroventricular administration. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/41438872 | PubMed |
| 41373793 | An AAV-Based Therapy Approach for Neurological Phenotypes of X-Linked Adrenoleukodystrophy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373793 | PubMed |
| 40956890 | PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40956890 | PubMed |
| 40837865 | CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models. | Regen Ther | 2025 | https://conductscience.org/library/papers/40837865 | PubMed |
| 40683992 | High-throughput evaluation of cardiac-specific promoters for adeno-associated virus mediated cardiac gene therapy. | Gene Ther | 2026 | https://conductscience.org/library/papers/40683992 | PubMed |
| 40454374 | Advances in viral vector-based delivery systems for gene therapy: a comprehensive review. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40454374 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39334366
GET https://conductscience.org/api/papers/v1/39334366/references?page=2